跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,950 条关于
“CRC MRD”
全部
9,950
临床试验
7,558
药物
916
机构
191
资讯
1,285
去年
AmMax Bio Doses First Patient in Phase 2a Trial of AMB-066 for Colorectal Cancer MRD
9个月前
Exelixis and Natera Launch Phase 3 Trial Testing Zanzalintinib in MRD-Positive Colorectal Cancer Patients
去年
Revuforj (Revumenib) Shows Promising Results in Acute Leukemia Trials
去年
Revumenib Demonstrates Sustained Responses in Relapsed/Refractory KMT2Ar Acute Leukemia
去年
ctDNA Testing Shows Promise in Guiding Colorectal Cancer Treatment Decisions
去年
Natera's Signatera Shows Promise in Colorectal Cancer MRD Detection and Early Detection
2年前
Signatera MRD Test Demonstrates Clinical Utility in Colorectal and Breast Cancer Studies
2年前
ctDNA Analysis Predicts Survival and Treatment Response in Colorectal Cancer
去年
Trastuzumab Plus Tucatinib and Fam-Trastuzumab Deruxtecan-nxki Show Promise in HER2-Positive Colorectal Cancer
2年前
Signatera MRD Test Predicts Overall Survival in Colorectal Cancer, GALAXY Study Shows
第 1 页,共 129 页
上一页
下一页